HEADER HYDROLASE 04-JUL-22 8AB5
TITLE STRUCTURE OF E. COLI GLPG IN COMPLEX WITH PEPTIDE DERIVED INHIBITOR
TITLE 2 AC-VRHA-CONH-[4-(4-BUTYL)-PHENOXY-1-PHENYL-2-BUTYL]
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: RHOMBOID PROTEASE GLPG;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: INTRAMEMBRANE SERINE PROTEASE;
COMPND 5 EC: 3.4.21.105;
COMPND 6 ENGINEERED: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: AC-VRHA-CONH-[4-(4-BUTYL)-PHENOXY-1-PHENYL-2-BUTYL];
COMPND 9 CHAIN: C, D;
COMPND 10 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K-12;
SOURCE 3 ORGANISM_TAXID: 83333;
SOURCE 4 GENE: GLPG, B3424, JW5687;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 7 MOL_ID: 2;
SOURCE 8 SYNTHETIC: YES;
SOURCE 9 ORGANISM_SCIENTIFIC: PROVIDENCIA STUARTII;
SOURCE 10 ORGANISM_TAXID: 588
KEYWDS RHOMBOID, PROTEASE, GLPG, KETOAMIDE, INHIBITOR, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR J.SKERLOVA,V.POLOVINKIN,K.BACH,V.BORSHCHEVSKIY,K.STRISOVSKY
REVDAT 3 13-NOV-24 8AB5 1 REMARK
REVDAT 2 10-JUL-24 8AB5 1 JRNL LINK
REVDAT 1 25-OCT-23 8AB5 0
JRNL AUTH K.BACH,J.DOHNALEK,J.SKERLOVA,J.KUZMIK,E.POLACHOVA,
JRNL AUTH 2 S.STANCHEV,P.MAJER,J.FANFRLIK,A.PECINA,J.REZAC,M.LEPSIK,
JRNL AUTH 3 V.BORSHCHEVSKIY,V.POLOVINKIN,K.STRISOVSKY
JRNL TITL EXTENSIVE TARGETING OF CHEMICAL SPACE AT THE PRIME SIDE OF
JRNL TITL 2 KETOAMIDE INHIBITORS OF RHOMBOID PROTEASES BY BRANCHED
JRNL TITL 3 SUBSTITUENTS EMPOWERS THEIR SELECTIVITY AND POTENCY.
JRNL REF EUR.J.MED.CHEM. V. 275 16606 2024
JRNL REFN ISSN 0223-5234
JRNL PMID 38901105
JRNL DOI 10.1016/J.EJMECH.2024.116606
REMARK 2
REMARK 2 RESOLUTION. 2.40 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.8.0232
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.50
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1
REMARK 3 NUMBER OF REFLECTIONS : 15659
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.220
REMARK 3 R VALUE (WORKING SET) : 0.218
REMARK 3 FREE R VALUE : 0.271
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300
REMARK 3 FREE R VALUE TEST SET COUNT : 868
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1082
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.15
REMARK 3 BIN R VALUE (WORKING SET) : 0.3100
REMARK 3 BIN FREE R VALUE SET COUNT : 51
REMARK 3 BIN FREE R VALUE : 0.3160
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2958
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 0
REMARK 3 SOLVENT ATOMS : 22
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.28
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 1.70000
REMARK 3 B22 (A**2) : 0.11000
REMARK 3 B33 (A**2) : -2.43000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 2.21000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.483
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.294
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3060 ; 0.007 ; 0.013
REMARK 3 BOND LENGTHS OTHERS (A): 2902 ; 0.034 ; 0.017
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4154 ; 1.387 ; 1.627
REMARK 3 BOND ANGLES OTHERS (DEGREES): 6632 ; 2.273 ; 1.593
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 360 ; 6.360 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 128 ;31.647 ;20.781
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 464 ;15.504 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;18.314 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 362 ; 0.065 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3352 ; 0.007 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): 760 ; 0.009 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY
REMARK 4
REMARK 4 8AB5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-JUL-22.
REMARK 100 THE DEPOSITION ID IS D_1292123355.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 20-NOV-21
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ESRF
REMARK 200 BEAMLINE : ID23-1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.7749
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS FEB 5, 2021 (BUILT 20210323)
REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.2
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16528
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400
REMARK 200 RESOLUTION RANGE LOW (A) : 29.500
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5
REMARK 200 DATA REDUNDANCY : 4.700
REMARK 200 R MERGE (I) : 0.09400
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49
REMARK 200 COMPLETENESS FOR SHELL (%) : 88.5
REMARK 200 DATA REDUNDANCY IN SHELL : 3.60
REMARK 200 R MERGE FOR SHELL (I) : 1.10300
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: 5MT6
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 53.94
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 2.65 M SODIUM MALONATE PH 7.5, LIPIDIC
REMARK 280 CUBIC PHASE, TEMPERATURE 295K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.43000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1520 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 9350 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1620 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 9010 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400
REMARK 400 THE AC-VRHA-CONH-[4-(4-BUTYL)-PHENOXY-1-PHENYL-2-BUTYL] IS PEPTIDE-
REMARK 400 LIKE, A MEMBER OF INHIBITOR CLASS.
REMARK 400
REMARK 400 GROUP: 1
REMARK 400 NAME: AC-VRHA-CONH-[4-(4-BUTYL)-PHENOXY-1-PHENYL-2-BUTYL]
REMARK 400 CHAIN: C, D
REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER
REMARK 400 DESCRIPTION: NULL
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLU A 91
REMARK 465 ARG A 92
REMARK 465 GLU B 91
REMARK 465 ARG B 92
DBREF 8AB5 A 91 270 UNP P09391 GLPG_ECOLI 91 270
DBREF 8AB5 B 91 270 UNP P09391 GLPG_ECOLI 91 270
DBREF 8AB5 C 1 5 PDB 8AB5 8AB5 1 5
DBREF 8AB5 D 1 5 PDB 8AB5 8AB5 1 5
SEQRES 1 A 180 GLU ARG ALA GLY PRO VAL THR TRP VAL MET MET ILE ALA
SEQRES 2 A 180 CYS VAL VAL VAL PHE ILE ALA MET GLN ILE LEU GLY ASP
SEQRES 3 A 180 GLN GLU VAL MET LEU TRP LEU ALA TRP PRO PHE ASP PRO
SEQRES 4 A 180 THR LEU LYS PHE GLU PHE TRP ARG TYR PHE THR HIS ALA
SEQRES 5 A 180 LEU MET HIS PHE SER LEU MET HIS ILE LEU PHE ASN LEU
SEQRES 6 A 180 LEU TRP TRP TRP TYR LEU GLY GLY ALA VAL GLU LYS ARG
SEQRES 7 A 180 LEU GLY SER GLY LYS LEU ILE VAL ILE THR LEU ILE SER
SEQRES 8 A 180 ALA LEU LEU SER GLY TYR VAL GLN GLN LYS PHE SER GLY
SEQRES 9 A 180 PRO TRP PHE GLY GLY LEU SER GLY VAL VAL TYR ALA LEU
SEQRES 10 A 180 MET GLY TYR VAL TRP LEU ARG GLY GLU ARG ASP PRO GLN
SEQRES 11 A 180 SER GLY ILE TYR LEU GLN ARG GLY LEU ILE ILE PHE ALA
SEQRES 12 A 180 LEU ILE TRP ILE VAL ALA GLY TRP PHE ASP LEU PHE GLY
SEQRES 13 A 180 MET SER MET ALA ASN GLY ALA HIS ILE ALA GLY LEU ALA
SEQRES 14 A 180 VAL GLY LEU ALA MET ALA PHE VAL ASP SER LEU
SEQRES 1 B 180 GLU ARG ALA GLY PRO VAL THR TRP VAL MET MET ILE ALA
SEQRES 2 B 180 CYS VAL VAL VAL PHE ILE ALA MET GLN ILE LEU GLY ASP
SEQRES 3 B 180 GLN GLU VAL MET LEU TRP LEU ALA TRP PRO PHE ASP PRO
SEQRES 4 B 180 THR LEU LYS PHE GLU PHE TRP ARG TYR PHE THR HIS ALA
SEQRES 5 B 180 LEU MET HIS PHE SER LEU MET HIS ILE LEU PHE ASN LEU
SEQRES 6 B 180 LEU TRP TRP TRP TYR LEU GLY GLY ALA VAL GLU LYS ARG
SEQRES 7 B 180 LEU GLY SER GLY LYS LEU ILE VAL ILE THR LEU ILE SER
SEQRES 8 B 180 ALA LEU LEU SER GLY TYR VAL GLN GLN LYS PHE SER GLY
SEQRES 9 B 180 PRO TRP PHE GLY GLY LEU SER GLY VAL VAL TYR ALA LEU
SEQRES 10 B 180 MET GLY TYR VAL TRP LEU ARG GLY GLU ARG ASP PRO GLN
SEQRES 11 B 180 SER GLY ILE TYR LEU GLN ARG GLY LEU ILE ILE PHE ALA
SEQRES 12 B 180 LEU ILE TRP ILE VAL ALA GLY TRP PHE ASP LEU PHE GLY
SEQRES 13 B 180 MET SER MET ALA ASN GLY ALA HIS ILE ALA GLY LEU ALA
SEQRES 14 B 180 VAL GLY LEU ALA MET ALA PHE VAL ASP SER LEU
SEQRES 1 C 5 ACE VAL ARG HIS LPV
SEQRES 1 D 5 ACE VAL ARG HIS LPV
HET ACE C 1 3
HET LPV C 5 29
HET ACE D 1 3
HET LPV D 5 29
HETNAM ACE ACETYL GROUP
HETNAM LPV (2~{R},3~{S})-3-AZANYL-~{N}-[(2~{R})-4-(4-
HETNAM 2 LPV BUTYLPHENOXY)-1-PHENYL-BUTAN-2-YL]-2-OXIDANYL-
HETNAM 3 LPV BUTANAMIDE
FORMUL 3 ACE 2(C2 H4 O)
FORMUL 3 LPV 2(C24 H34 N2 O3)
FORMUL 5 HOH *22(H2 O)
HELIX 1 AA1 GLY A 94 GLY A 115 1 22
HELIX 2 AA2 GLY A 115 ALA A 124 1 10
HELIX 3 AA3 ASP A 128 LYS A 132 5 5
HELIX 4 AA4 TRP A 136 HIS A 141 1 6
HELIX 5 AA5 ALA A 142 MET A 144 5 3
HELIX 6 AA6 SER A 147 GLY A 170 1 24
HELIX 7 AA7 GLY A 170 GLY A 194 1 25
HELIX 8 AA8 LEU A 200 ASP A 218 1 19
HELIX 9 AA9 PRO A 219 GLY A 222 5 4
HELIX 10 AB1 GLN A 226 PHE A 242 1 17
HELIX 11 AB2 ALA A 250 SER A 269 1 20
HELIX 12 AB3 GLY B 94 GLY B 115 1 22
HELIX 13 AB4 GLY B 115 ALA B 124 1 10
HELIX 14 AB5 ASP B 128 LYS B 132 5 5
HELIX 15 AB6 TRP B 136 HIS B 141 1 6
HELIX 16 AB7 ALA B 142 MET B 144 5 3
HELIX 17 AB8 SER B 147 GLY B 170 1 24
HELIX 18 AB9 GLY B 170 GLY B 194 1 25
HELIX 19 AC1 LEU B 200 ASP B 218 1 19
HELIX 20 AC2 PRO B 219 GLY B 222 5 4
HELIX 21 AC3 GLN B 226 ASP B 243 1 18
HELIX 22 AC4 LEU B 244 MET B 247 5 4
HELIX 23 AC5 ALA B 250 LEU B 270 1 21
LINK OG SER A 201 C2 LPV C 5 1555 1555 1.43
LINK OG SER B 201 C2 LPV D 5 1555 1555 1.43
LINK C ACE C 1 N VAL C 2 1555 1555 1.33
LINK C HIS C 4 N2 LPV C 5 1555 1555 1.36
LINK C ACE D 1 N VAL D 2 1555 1555 1.33
LINK C HIS D 4 N2 LPV D 5 1555 1555 1.36
CRYST1 48.540 70.860 66.000 90.00 100.06 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.020602 0.000000 0.003655 0.00000
SCALE2 0.000000 0.014112 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015388 0.00000